CD28 and LFA-1 contribute to cyclosporin A-resistant T coil growth by stabilizing the IL-2 mRNA through distinct signaling pathways

European Journal of Immunology

Volumn 30, Issue 4, 2000, Pages 1136-1144

  Geginat, Jens ^a,b   Clissi, Barbara ^a   Moro, Monica ^a   Dellabona, Paolo ^a   Bender, Jeffrey R ^c   Pardi, Ruggero ^a,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Cell proliferation; Co stimulatory molecule; Cyclosporin A; IL 2; T lymphocyte

Indexed keywords

ACTIN; CD28 ANTIGEN; CD86 ANTIGEN; CYCLOSPORIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; HALF LIFE TIME; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RNA DEGRADATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD86; CALCINEURIN; CELLS, CULTURED; CYCLOSPORINE; CYTOSKELETON; DENDRITIC CELLS; DNA-BINDING PROTEINS; DRUG SYNERGISM; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA STABILITY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPERANTIGENS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 0033997963     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200004)30:4<1136::AID-IMMU1136>3.0.CO;2-3     Document Type: Article

References (38)

1. Lanzavecchia, A., Iezzi, G. and Viola, A., From TCR engagement to T cell activation: A kinetic view of T cell behavior. Cell 1999. 96: 1-4
2. Croft, M. and Dubey, C., Accessory molecule and co-stimulation requirements for CD4 T cell response. Crit. Rev. Immunol. 1997. 17: 89-118
3. Lenschow, D.J. and Bluestone, J.A., T cell co-stimulation and in vivo tolerance. Curr. Opin. Immunol. 1993. 5: 747-752
4. Lenschow, D.J., Walunas, T.L. and Bluestone, J.A., CD28/B7 system of T cell co-stimulation. Annu. Rev. Immunol. 1996. 14: 233-258.
5. Bachmann, M.F., McKall-Faienza, K., Schmits, R., Bouchard, D., Beach, J., Speiser, D.E., Mak, T.W. and Ohashi, P.S., Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus co-stimulation. Immunity 1997. 7: 549-557.
6. Damle, N.K., Klussman, K., Linsley, P.S. and Aruffo, A., Differential co-stimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J. Immunol. 1992. 148: 1985-1992.
7. Dubey, C., Croft, M. and Swain, S.L., Co-stimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J. Immunol. 1995. 155: 45-57.
8. Geginat, J., Bossi, G., Bender, J.R. and Pardi, R., Anchorage dependence of mitogen-induced G1 to S transition in primary T lymphocytes. J. Immunol. 1999. 162: 5085-5093.
9. Jain, J., Loh, C. and Rao, A., Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 1995. 7: 333-342.
10. Ward, S.G., Parry, R.V., Matthews, J. and O'Neill, L., A p38 MAP kinase inhibitor SB203580 inhibits CD28-dependent T cell proliferation and IL-2 production. Biochem. Soc. Trans. 1997. 25: 304S.
11. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M. and Ben-Neriah, Y., JNK is involved in signal integration during co-stimulation of T lymphocytes. Cell 1994. 77: 727-736.
12. Whitehurst, C.E. and Geppert, T.D., MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. J. Immunol. 1996. 156: 1020-1029.
13. Su, B. and Karin, M., Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 1996. 8: 402-411.
14. Chen, C.Y., Del Gatto-Konczak, F., Wu, Z. and Karin, M., Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998. 280: 1945-1949.
15. Ming, X.F., Kaiser, M. and Moroni, C., c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EMBO J. 1998. 17:6039-6048.
16. Liu, J., FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol. Today 1993. 14: 290-295.
17. Marienfeld, R., Neumann, M., Chuvpilo, S., Escher, C., Kneitz, B., Avots, A., Schimpl, A. and Serfling, E., Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. Eur. J. Immunol. 1997. 27: 1601-1609.
18. Nunes, J.A., Collette, Y., Truneh, A., Olive, D. and Cantrell, D.A., The role of p21 ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21 ras. J. Exp. Med. 1994. 180: 1067-1076.
19. Van Gool, S.W., Ceuppens, J.L., Walter, H. and de Boer, M., Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation. Blood 1994. 83: 176-183.
20. Van Gool, S.W., de Boer, M. and Ceuppens, J.L., CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J. Immunol. 1993. 150: 3254-3263.
21. Galvin, F., Freeman, G.J., Razi-Wolf, Z., Benacerraf, B., Nadler, L., and Reiser, H., Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen. Eur. J. Immunol. 1993. 23: 283-286.
22. Karmann, K., Pober, J.S. and Hughes, C.C., Endothelial cell-induced resistance to cyclosporin A in human peripheral blood T cells requires contact-dependent interactions involving CD2 but not CD28. J. Immunol. 1994. 153: 3929-3937.
23. Valitutti, S. and Lanzavecchia, A., Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol. Today 1997. 18: 299-304.
24. Li, H., Liera, A., Malchiodi, E.L. and Mariuzza, R.A., The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 1999. 17: 435-466.
25. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage-colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor. J. Exp. Med. 1994. 179: 1109-1118.
26. van Kooyk, Y., van de Wiel-van Kemenade, P., Weder, P., Kuijpers, T.W. and Figdor, C.G., Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 1989. 342: 811-813.
27. Dustin, M.L. and Springer, T.A., T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989. 341: 619-624.
28. Berg, N.N. and Ostergaard, H.L., Characterization of intercellular adhesion molecule-1 (ICAM-1)-augmented degranulation by cytotoxic T cells. ICAM-1 and anti-CD3 must be co-localized for optimal adhesion and stimulation. J. Immunol. 1995. 155: 1694-1702.
29. Giri, J.G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L.S., Cosman, D. and Andersen, D., Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994. 13: 2822-2830.
30. Lin, J.X., Migone, T.S., Tsang, M. et al., The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995. 2: 331-339.
31. Kundig, T.M., Schorle H., Bachmann, M.F., Hengartner, H., Zinkernagel, R.M. and Horak, I., Immune responses in interleukin-2-deficient mice. Science 1993. 262: 1059-1061.
32. Timmerman, L.A., Clipstone, N.A., Ho, S.N., Northrop, J.P. and Crabtree, G.R., Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature 1996. 383: 837-840.
33. Venkataraman, L., Burakoff, S.J. and Sen, R., FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 1995. 181: 1091-1099.
34. Kalli, K., Huntoon, C., Bell, M. and McKean, D.J., Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB. Mol. Cell. Biol. 1998. 18: 3140-3148.
35. Dong, C., Yang, D.D., Wysk, M., Whitmarsh, A.J., Davis, R.J. and Flavell, R.A., Defective T cell differentiation in the absence of Jnk1. Science 1998. 282: 2092-2095.
36. Yoshida, H., Nishina, H., Takimoto, H., Marengere, L.E., Wakeham, A.C., Bouchard, D., Kong, Y.Y., Ohteki, T, Shahinian, A., Bachmann, M., Ohashi, P.S., Penninger, J.M., Crabtree, G.R. and Mak, T.W., The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 1998. 8: 115-124.
37. Hodge, M.R., Ranger, A.M., Charles de la Brousse, F., Hoey, T., Grusby, M.J. and Glimcher, L.H., Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 1996. 4: 397-405.
38. Wang, G.J., Collinge, M., Blasi, F., Pardi, R. and Bender, J.R., Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. Proc. Natl. Acad. Sci. USA 1998. 95: 6296-6301.